| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Havencrest Healthcare Partners, L.P. last filed a Form 4 in August 2024, as 10% Owner at TOI.
Our model assigns Havencrest Healthcare Partners, L.P. a strong insider score of 92/100, based on 68 past trades. Over a 12-month horizon, 98.5% of those trades were profitable, with an average 12-month return of +67.2%.
Havencrest Healthcare Partners, L.P. has 26 Form 4 filings on record from August 2022 to August 2024, all as 10% Owner at Oncology Institute (TOI), 2022–2024.
The 72 reported transactions were 68 open-market sales and 4 other transactions.
Counted by filing, the open-market trades come to no purchases and 24 sales worth about $10.5M.
The largest open-market sale was 288,129 shares of TOI at an average $4.50 on September 19, 2022, about $1.3M. Twelve months later TOI was down 65%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 8,637 | $2.12 | $18,310.44 | -100% | -49.8% | -63.6% | |
| Jan 26, 2024 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 43,776 | $2.21 | $96,835.30 | -83.5% | -44.6% | -64.3% | |
| Jan 23, 2024 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 27,587 | $2.12 | $58,550.92 | -34.5% | -46.4% | -66.6% | |
| Nov 11, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 365,321 | $2.33 | $851,197.93 | -2.7% | -31.8% | +13.8% | |
| Nov 10, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 168,281 | $3.07 | $517,297.38 | -1.2% | -48.3% | -16.0% | |
| Nov 7, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 114,867 | $3.45 | $395,935.76 | -0.8% | -54.0% | -47.0% | |
| Nov 2, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 150,627 | $4.26 | $640,948.67 | -1.1% | -61.5% | -50.3% | |
| Oct 28, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 139,591 | $5.02 | $701,170.44 | -1.0% | -69.8% | -60.9% | |
| Oct 25, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 79,800 | $5.02 | $400,652.00 | -0.6% | -71.8% | -67.3% | |
| Oct 20, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 41,700 | $4.71 | $196,346.00 | -0.3% | -65.6% | -67.7% |